MOH (Biotech stock) has been consolidating tightly at ATH. There is clear R/S in this name despite the recent market weakness. On the 65m chart, MOH cleared the HVN above 172 and looks primed for continuation next week. Went long at the HVN break and above the intraday higher high.
Entry - 172.96
Stop Loss - 165
Target - 200
I will continue to update this post as the trade develops.
Entry - 172.96
Stop Loss - 165
Target - 200
I will continue to update this post as the trade develops.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。